Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00342407 · ClinicalTrials.gov registry record

The Incidence of Breast and Other Cancers Among Female Flight Attendants

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status
6,093
Enrollment target

NCT00342407: Completed study, sponsored by National Cancer Institute (NCI).

NCT00342407 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 6,093 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00342407 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
6,093 participants
Enrollment target

Study Summary

Flight attendants may be at an increased risk of breast and other cancers due to work-place exposures including cosmic radiation and circadian rhythm disruption form traveling across multiple time zones. This cancer incidence study will determine whether female flight attendants are at increased risk of breast and other cancers and whether the risk is dose-related. The study will include a cohort of approximately 10,000 women who were employed as flight attendants for one or more years. Breast cancer cases will be identified from telephone interviews of living subjects and next-of-kin of deceased subjects, as well as from death certificates. The interview will also provide information about non-occupational risk factors for breast cancer such as parity. Both internal and external comparisons will be made. The primary analysis will evaluate the risk associated with occupational exposure within the cohort, controlling for non-occupational risk factors by stratification or modeling. The secondary analysis will compare the incidence of breast cancer in the cohort to that in the general population, with adjustment for factors such as lower parity which might increase breast cancer risk in the cohort independent of occupational exposure to cosmic radiation and circadian rhythm disruption. The risk of other ionizing radiation-related cancers, such as leukemia, lung cancer, and thyroid cancer, among flight attendants will also be evaluated. The results of the study will apply to female flight crew and frequent fliers.

Trial Details

FieldValue
Enrollment Target 6,093 participants
Start Date 2001-11-06
Est. Completion 2020-04-09

Sponsor

National Cancer Institute (NCI)

3,257 total trials

What the Registry Record Tells You About NCT00342407

The ClinicalTrials.gov registry entry for NCT00342407 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6,093 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00342407 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00342407 about?

NCT00342407 is a clinical study titled "The Incidence of Breast and Other Cancers Among Female Flight Attendants". Flight attendants may be at an increased risk of breast and other cancers due to work-place exposures including cosmic radiation and circadian rhythm disruption form traveling across multiple time zones. This cancer incidence study will determine whether female flight attendants are at increased ris...

What is the current status of trial NCT00342407?

This trial is currently completed. The enrollment target is 6,093 participants. The study started on 2001-11-06. Estimated completion is 2020-04-09.

Who is sponsoring clinical trial NCT00342407?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.